Syntegon Group appoints Dr. Peter Hackel as Chief Financial Officer

4 mins read

Waiblingen/Germany, The Syntegon Group, a globally leading
supplier of processing and packaging technology, intends to appoint Dr. Peter Hackel
as member of the Executive Board at the beginning of 2023. In his new position, as
Chief Financial Officer (CFO) Peter Hackel will be responsible for Finance &
Controlling, Foreign Trade and IT of Syntegon. He will be located at Beringen,
Switzerland.
Peter Hackel is a well-rounded, highly accomplished executive, experienced within
Sales as well as in Finance and in this capacity has served as Chief Financial Officer
in different companies for more than nine years. He started his career with McKinsey
& Company Inc. followed by Geistlich Pharma AG, Oerlikon Corporation AG and most
recently at Straumann Holding AG, where he has significantly contributed to the
positive development of the company as Group Chief Financial Officer and member of
the Group Executive Management Board since 2014. He successfully led growth and
restructuring projects, among others as responsible for Finance, Investor Relations,
IT, Operational Excellence, Procurement and Sustainability. He holds a PhD degree
in Molecular Biology from the Swiss Federal Institute of Technology (ETH) in Zurich,
Switzerland, and studied Business Administration at the University of Hagen,
Germany.
“We are very pleased to have won Peter Hackel, an extremely experienced and
successful manager, for Syntegon. Almost two decades of management expertise in
Operations, Finance and Business Management in different industries and an
international network are excellent prerequisites to further advance the successful
development of Syntegon”, says Dr. Michael Grosse, CEO of the Syntegon Group.
From the beginning of 2023, Dr. Walter Bickel, member of the Executive Board of
Syntegon with responsibility for Transformation (CTO) and since July 01, 2020
additionally as Chief Financial Officer (CFO), shall continue to focus on the further
implementation of Syntegon’s successful transformation projects. Likewise, Walter
Bickel shall remain responsible for Human Resources, Supply Chain, Business &
Project Excellence at Syntegon. With his experience and extraordinary expertise, he
will continue to contribute significantly to the success of the Syntegon Group.

About Syntegon Technology
Processing and packaging for a better life – this is what 5,800 Syntegon employees
work for every day. Be it with individual machines, systems, or services, Syntegon
helps its customers in the global pharmaceutical and food industries to improve
people’s lives. The company, which is headquartered in Waiblingen, Germany, looks
back on more than 160 years of experience and achieved annual sales of 1.4 billion
EUR in 2021. In the pharma sector, the company’s intelligent solutions enable the
safe and high-quality production, processing, filling, inspection, and packaging of
liquid and solid pharmaceuticals. In the food industry, Syntegon’s flexible and reliable
technologies produce and pack confectionery, dry food, frozen food, and dairy
products. With 1,100 service experts and a comprehensive service portfolio
throughout the entire machine lifecycle from spare parts management to digital line
optimization, Syntegon lays the foundation for smooth production processes for all
customers. More than 30 sites in almost 20 countries keep a firm eye on Syntegon’s
impact on the environment and society. Syntegon is a leader in the development of
sustainable packaging solutions, reduces the energy consumption of its machines
and pursues ambitious goals to lower its emissions. www.syntegon.com

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous Story

Almirall:Tildrakizumab is the first and only IL-23p19 inhibitor to demonstrate meaningful sleep improvement in people living with psoriasis

Next Story

Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022